FBIOP
Fortress Biotech Inc Pref Series ANASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$77.81M
P/E Ratio
—
EPS
$-0.86
Beta
1.16
52W High
$21.23
52W Low
$6.27
50-Day MA
$15.81
200-Day MA
$11.29
Dividend Yield
—
Profit Margin
10.80%
Forward P/E
—
PEG Ratio
—
About Fortress Biotech Inc Pref Series A
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $63.26M |
| Gross Profit (TTM) | $30.44M |
| EBITDA | $-65.56M |
| Operating Margin | -29.80% |
| Return on Equity | -108.70% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $2.27 |
| Book Value | $1.59 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 1.23 |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.30% |
| Shares Outstanding | $56.68M |
| Float | $22.38M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
33.92%
HV 20-Day
47.40%
HV 30-Day
47.23%
HV 60-Day
39.49%
HV Rank
23.8%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026